Anti-human PD-L1 antibodies and their uses
AssigneeDevelopment Center for Biotechnology
InventorsShu-Ping Yeh, Cheng-Chou Yu, Yu-Hsun Lo, Jin-Yu Wang, Mei-Chi Chan, Chao-Yang Huang, Szu-Liang Lai
Life of this patent
Estimating the term…
Loading patent…
AssigneeDevelopment Center for Biotechnology
InventorsShu-Ping Yeh, Cheng-Chou Yu, Yu-Hsun Lo, Jin-Yu Wang, Mei-Chi Chan, Chao-Yang Huang, Szu-Liang Lai
Estimating the term…
The present disclosure relates to an anti-PD-L1 antibody or an antigen-binding fragment thereof, comprising: a heavy chain variable region sequence comprising the three CDRs with the sequences of SEQ ID NOs: 2 to 4, or 6 to 8; and a light chain variable region sequence comprising the three CDRs with the sequences of SEQ ID NOs: 10 to 12, or 14 to 16. The present disclosure also relates to a pharmaceutical composition and a method for detecting expression of PD-L1 in a sample.
An anti-PD-L1 antibody or an antigen-binding fragment thereof, comprising complementarity determining regions (CDRs) of a heavy chain variable region and complementarity determining regions of a light chain variable region, wherein
Dependencies are inferred from the claim text.